CYAXXVI Trademark
Trademark Overview
On Monday, January 29, 2024, a trademark application was filed for CYAXXVI with the United States Patent and Trademark Office. The USPTO has given the CYAXXVI trademark a serial number of 98381209. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 6, 2024. This trademark is owned by Renibus Therapeutics, Inc.. The CYAXXVI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement
General Information
| Serial Number | 98381209 |
| Word Mark | CYAXXVI |
| Filing Date | Monday, January 29, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, November 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Renibus Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Southlake, TX 76092 |
Trademark Events
| Event Date | Event Description |
| Monday, January 29, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 23, 2024 | ASSIGNED TO EXAMINER |
| Thursday, October 31, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 2, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, September 2, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, September 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, November 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
